These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 889300

  • 1. Ocular dyskinesias in patients with Parkinson's disease treated with levodopa.
    Shimizu N, Cohen B, Bala SP, Mendoza M, Yahr MD.
    Ann Neurol; 1977 Feb; 1(2):167-71. PubMed ID: 889300
    [No Abstract] [Full Text] [Related]

  • 2. [Motor complications in patients with Parkinson disease treated with levodopa].
    Luquin MR, Obeso JA, Martínez-Lage JM.
    Neurologia; 1989 Feb; 4(1):4-11. PubMed ID: 2631806
    [Abstract] [Full Text] [Related]

  • 3. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
    Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE.
    Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
    [Abstract] [Full Text] [Related]

  • 4. Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease.
    LeWitt PA.
    Mov Disord; 1998 Jul; 13(4):731-4. PubMed ID: 9686783
    [Abstract] [Full Text] [Related]

  • 5. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA.
    Mov Disord; 2005 Sep; 20(9):1205-9. PubMed ID: 15954135
    [Abstract] [Full Text] [Related]

  • 6. L-dopa induced dyskinesias in asymmetrical parkinsonism.
    Murphy MJ.
    Acta Neurol Latinoam; 1979 Sep; 25(1-2):47-52. PubMed ID: 583384
    [Abstract] [Full Text] [Related]

  • 7. Isoniazid therapy in Parkinson's disease.
    Gershanik OS, Luquin MR, Scipioni O, Obeso JA.
    Mov Disord; 1988 Sep; 3(2):133-9. PubMed ID: 3221901
    [Abstract] [Full Text] [Related]

  • 8. [Two cases of Parkinson's disease with diphasic dyskinesia, seen during levodopa treatment (author's transl)].
    Mano Y, Ando K, Muramoto O, Riku S.
    Rinsho Shinkeigaku; 1982 Mar; 22(3):209-15. PubMed ID: 7105593
    [No Abstract] [Full Text] [Related]

  • 9. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
    Bejjani BP, Arnulf I, Demeret S, Damier P, Bonnet AM, Houeto JL, Agid Y.
    Ann Neurol; 2000 May; 47(5):655-8. PubMed ID: 10805339
    [Abstract] [Full Text] [Related]

  • 10. [Anticholinergics and levodopa in Parkinson's disease: an unnecessary combination in patients treated for the 1st time].
    Giménez-Roldán S, Mateo D, Gil Núñez A.
    Rev Clin Esp; 1980 Dec 31; 159(6):403-7. PubMed ID: 7221107
    [No Abstract] [Full Text] [Related]

  • 11. Rating scales for dyskinesias in Parkinson's disease.
    Goetz CG.
    Mov Disord; 1999 Dec 31; 14 Suppl 1():48-53. PubMed ID: 10493403
    [No Abstract] [Full Text] [Related]

  • 12. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
    Marconi R, Lefebvre-Caparros D, Bonnet AM, Vidailhet M, Dubois B, Agid Y.
    Mov Disord; 1994 Jan 31; 9(1):2-12. PubMed ID: 8139601
    [Abstract] [Full Text] [Related]

  • 13. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R.
    Brain; 2006 Apr 31; 129(Pt 4):1059-69. PubMed ID: 16476674
    [Abstract] [Full Text] [Related]

  • 14. Current controversies: levodopa in the treatment of Parkinson's disease.
    Sharma JC, Vassallo M, Ross IN.
    Mov Disord; 2005 May 31; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
    [No Abstract] [Full Text] [Related]

  • 15. The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
    Vidailhet M, Bonnet AM, Marconi R, Durif F, Agid Y.
    Mov Disord; 1999 May 31; 14 Suppl 1():13-8. PubMed ID: 10493399
    [No Abstract] [Full Text] [Related]

  • 16. Sickness due to levodopa-induced neck dyskinesias in Parkinson's disease.
    Steiger MJ, Quinn NP, Marsden CD.
    Mov Disord; 1991 May 31; 6(1):91-2. PubMed ID: 2005934
    [No Abstract] [Full Text] [Related]

  • 17. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease.
    Alonso-Frech F, Zamarbide I, Alegre M, Rodríguez-Oroz MC, Guridi J, Manrique M, Valencia M, Artieda J, Obeso JA.
    Brain; 2006 Jul 31; 129(Pt 7):1748-57. PubMed ID: 16684788
    [Abstract] [Full Text] [Related]

  • 18. Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on L-dopa monotherapy.
    Mazzella L, Yahr MD, Marinelli L, Huang N, Moshier E, Di Rocco A.
    Parkinsonism Relat Disord; 2005 May 31; 11(3):151-5. PubMed ID: 15823479
    [Abstract] [Full Text] [Related]

  • 19. L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
    Rascol O.
    Mov Disord; 1999 May 31; 14 Suppl 1():19-32. PubMed ID: 10493400
    [No Abstract] [Full Text] [Related]

  • 20. [Dyskinesias induced by L-DOPA in Parkinson patients].
    García de Yébenes J, Muradas V, Bazán E, Reiriz J, Mena MA.
    Arch Neurobiol (Madr); 1985 May 31; 48(4):197-209. PubMed ID: 4074075
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.